A novel model of SCID-X1 reconstitution reveals predisposition to retrovirus-induced lymphoma but no evidence of ¿C gene oncogenicity

Linda Scobie; R. Hector; Louise Grant; Margaret Bell; Anne A. Neilsen; Sharon Meikle; Adrain Philbey; Adrain J. Thrasher

doi:10.1038/mt.2009.59

A novel model of SCID-X1 reconstitution reveals predisposition to retrovirus-induced lymphoma but no evidence of ¿C gene oncogenicity

Linda Scobie, R. Hector, Louise Grant, Margaret Bell, Anne A. Neilsen, Sharon Meikle, Adrain Philbey, Adrain J. Thrasher

Biological and Biomedical Sciences

Research output: Contribution to journal › Article › peer-review

Abstract

he emergence of leukemia following gene transfer to restore common cytokine receptor ¿ chain (¿C) function in X-linked severe combined immunodeficiency (SCID-X1) has raised important questions with respect to gene therapy safety. To explore the risk factors involved, we tested the oncogenic potential of human ¿C in new strains of transgenic mice expressing the gene under the control of the CD2 promoter and locus control region (LCR).

Original language	English
Pages (from-to)	1031-1038
Number of pages	8
Journal	Molecular Therapy
Volume	17
Issue number	6
DOIs	https://doi.org/10.1038/mt.2009.59
Publication status	Published - 1 Mar 2009

Keywords

gene therapy
leukemia
cytokine receptors

Documents and Links

10.1038/mt.2009.59

Fingerprint Dive into the research topics of 'A novel model of SCID-X1 reconstitution reveals predisposition to retrovirus-induced lymphoma but no evidence of ¿C gene oncogenicity'. Together they form a unique fingerprint.

Cite this

@article{fb9edac6f8004f65be367f8383d13df5,

title = "A novel model of SCID-X1 reconstitution reveals predisposition to retrovirus-induced lymphoma but no evidence of ¿C gene oncogenicity",

abstract = "he emergence of leukemia following gene transfer to restore common cytokine receptor ¿ chain (¿C) function in X-linked severe combined immunodeficiency (SCID-X1) has raised important questions with respect to gene therapy safety. To explore the risk factors involved, we tested the oncogenic potential of human ¿C in new strains of transgenic mice expressing the gene under the control of the CD2 promoter and locus control region (LCR).",

keywords = "gene therapy, leukemia, cytokine receptors",

author = "Linda Scobie and R. Hector and Louise Grant and Margaret Bell and Neilsen, {Anne A.} and Sharon Meikle and Adrain Philbey and Thrasher, {Adrain J.}",

note = "Originally published in: Molecular Therapy (2009), 17 (2), pp.1031-1038.",

year = "2009",

month = mar,

day = "1",

doi = "10.1038/mt.2009.59",

language = "English",

volume = "17",

pages = "1031--1038",

journal = "Molecular Therapy",

issn = "1525-0016",

publisher = "Cell Press",

number = "6",

}

A novel model of SCID-X1 reconstitution reveals predisposition to retrovirus-induced lymphoma but no evidence of ¿C gene oncogenicity. / Scobie, Linda; Hector, R.; Grant, Louise; Bell, Margaret; Neilsen, Anne A.; Meikle, Sharon; Philbey, Adrain; Thrasher, Adrain J.

In: Molecular Therapy, Vol. 17, No. 6, 01.03.2009, p. 1031-1038.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - A novel model of SCID-X1 reconstitution reveals predisposition to retrovirus-induced lymphoma but no evidence of ¿C gene oncogenicity

AU - Scobie, Linda

AU - Hector, R.

AU - Grant, Louise

AU - Bell, Margaret

AU - Neilsen, Anne A.

AU - Meikle, Sharon

AU - Philbey, Adrain

AU - Thrasher, Adrain J.

N1 - Originally published in: Molecular Therapy (2009), 17 (2), pp.1031-1038.

PY - 2009/3/1

Y1 - 2009/3/1

N2 - he emergence of leukemia following gene transfer to restore common cytokine receptor ¿ chain (¿C) function in X-linked severe combined immunodeficiency (SCID-X1) has raised important questions with respect to gene therapy safety. To explore the risk factors involved, we tested the oncogenic potential of human ¿C in new strains of transgenic mice expressing the gene under the control of the CD2 promoter and locus control region (LCR).

AB - he emergence of leukemia following gene transfer to restore common cytokine receptor ¿ chain (¿C) function in X-linked severe combined immunodeficiency (SCID-X1) has raised important questions with respect to gene therapy safety. To explore the risk factors involved, we tested the oncogenic potential of human ¿C in new strains of transgenic mice expressing the gene under the control of the CD2 promoter and locus control region (LCR).

KW - gene therapy

KW - leukemia

KW - cytokine receptors

UR - http://www.scopus.com/inward/record.url?eid=2-s2.0-67349162619&partnerID=8YFLogxK

U2 - 10.1038/mt.2009.59

DO - 10.1038/mt.2009.59

M3 - Article

VL - 17

SP - 1031

EP - 1038

JO - Molecular Therapy

JF - Molecular Therapy

SN - 1525-0016

IS - 6

ER -